Drug intelligence / Profile preview

cefoperazone + metronidazole

Development stage
Phase 4
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous
01

Overview

Cefoperazone + metronidazole is a combination of two antibiotics used primarily for the prevention and treatment of infections, especially those involving mixed aerobic and anaerobic bacteria. Cefoperazone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, providing broad-spectrum activity against many Gram-negative and some Gram-positive organisms. Metronidazole is a nitroimidazole antibiotic effective against most anaerobic bacteria and certain protozoa; it works by disrupting DNA synthesis in susceptible organisms. This combination is commonly used as surgical prophylaxis in procedures with high risk of anaerobic infection (such as hepatobiliary, colorectal, or upper gastrointestinal surgeries) and for treating intra-abdominal infections[1][5]. The combined use targets both aerobic pathogens (cefoperazone) and anaerobes (metronidazole), reducing postoperative infectious complications more effectively than monotherapy[1][5].

02

Targets

NeuraminidasePBP (Penicillin-binding protein family)DNA polymerase III (DNA polymerase III (bacterial))

Beyond the preview

Go deeper on cefoperazone + metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefoperazone + metronidazole.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call